| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/000348940111000710 |
| P698 | PubMed publication ID | 11465824 |
| P2093 | author name string | N Kim | |
| M Barbieri | |||
| K C Cheng | |||
| R Mora | |||
| T J Yoo | |||
| S S Kwon | |||
| P2860 | cites work | Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin | Q37622936 |
| Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity | Q40976342 | ||
| Oral tolerance: immune mechanisms and treatment of autoimmune diseases | Q41546336 | ||
| Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides | Q41650198 | ||
| Gamma-interferon-induced activation of latent transforming growth factor-beta by human monocytes | Q41754784 | ||
| Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent | Q42935742 | ||
| Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig | Q43910342 | ||
| Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide | Q45146675 | ||
| Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein | Q46690191 | ||
| Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. | Q50592606 | ||
| Tolerance induction by a poorly arthritogenic collagen II can prevent collagen-induced arthritis | Q54378723 | ||
| Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory | Q34225394 | ||
| Specific T-cell tolerance may reflect selective activation of lymphokine synthesis | Q34581164 | ||
| Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. | Q35591418 | ||
| Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance | Q35878983 | ||
| A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes | Q36140954 | ||
| Antigen-driven bystander suppression after oral administration of antigens | Q36230404 | ||
| Autoimmunity to type II collagen an experimental model of arthritis | Q36335891 | ||
| Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen | Q36345483 | ||
| Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule | Q36350627 | ||
| Induction of arthritis in monkeys by immunization with type II collagen | Q36355205 | ||
| Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen | Q37401915 | ||
| Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit | Q37494112 | ||
| P433 | issue | 7 Pt 1 | |
| P921 | main subject | cholera | Q12090 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 646-654 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Annals of Otology Rhinology and Laryngology | Q2646761 |
| P1476 | title | Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease | |
| P478 | volume | 110 |
| Q35155875 | AB toxins: a paradigm switch from deadly to desirable |
| Q45867292 | Adoptive Cellular Gene Therapy for the Treatment of Experimental Autoimmune Polychondritis Ear Disease |
| Q34113929 | Autoantigens plus interleukin-10 suppress diabetes autoimmunity |
| Q39971245 | Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation |
| Q78445849 | Diminished immunopathology in Schistosoma mansoni infection following intranasal administration of cholera toxin B-immunodominant peptide conjugate correlates with enhanced transforming growth factor-beta production by CD4 T cells |
| Q35619878 | Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent |
| Q30480826 | Induction of tolerance by oral administration of beta-tubulin in an animal model of autoimmune inner ear disease |
| Q37657673 | Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit |
| Q40609980 | Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis. |
| Q37351448 | Persistent suppression of type 1 diabetes by a multicomponent vaccine containing a cholera toxin B subunit-autoantigen fusion protein and complete Freund's adjuvant |
| Q34629092 | Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. |
| Q39233053 | The Role of Dendritic Cell Maturation in the Induction of Insulin-Dependent Diabetes Mellitus |
| Q35884229 | The immunobiology of Th1 polarization in high-pathology schistosomiasis |
Search more.